Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

570 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Liposomes bi-functionalized with phosphatidic acid and an ApoE-derived peptide affect Aβ aggregation features and cross the blood-brain-barrier: implications for therapy of Alzheimer disease.
Bana L, Minniti S, Salvati E, Sesana S, Zambelli V, Cagnotto A, Orlando A, Cazzaniga E, Zwart R, Scheper W, Masserini M, Re F. Bana L, et al. Among authors: salvati e. Nanomedicine. 2014 Oct;10(7):1583-90. doi: 10.1016/j.nano.2013.12.001. Epub 2013 Dec 10. Nanomedicine. 2014. PMID: 24333591
Retro-inverso peptide inhibitor nanoparticles as potent inhibitors of aggregation of the Alzheimer's Aβ peptide.
Gregori M, Taylor M, Salvati E, Re F, Mancini S, Balducci C, Forloni G, Zambelli V, Sesana S, Michael M, Michail C, Tinker-Mill C, Kolosov O, Sherer M, Harris S, Fullwood NJ, Masserini M, Allsop D. Gregori M, et al. Among authors: salvati e. Nanomedicine. 2017 Feb;13(2):723-732. doi: 10.1016/j.nano.2016.10.006. Epub 2016 Oct 19. Nanomedicine. 2017. PMID: 27769888 Free article.
A novel retro-inverso peptide inhibitor reduces amyloid deposition, oxidation and inflammation and stimulates neurogenesis in the APPswe/PS1ΔE9 mouse model of Alzheimer's disease.
Parthsarathy V, McClean PL, Hölscher C, Taylor M, Tinker C, Jones G, Kolosov O, Salvati E, Gregori M, Masserini M, Allsop D. Parthsarathy V, et al. Among authors: salvati e. PLoS One. 2013;8(1):e54769. doi: 10.1371/journal.pone.0054769. Epub 2013 Jan 31. PLoS One. 2013. PMID: 23382963 Free PMC article.
Ceramides and sphingomyelinases in senile plaques.
Panchal M, Gaudin M, Lazar AN, Salvati E, Rivals I, Ayciriex S, Dauphinot L, Dargère D, Auzeil N, Masserini M, Laprévote O, Duyckaerts C. Panchal M, et al. Among authors: salvati e. Neurobiol Dis. 2014 May;65:193-201. doi: 10.1016/j.nbd.2014.01.010. Epub 2014 Jan 28. Neurobiol Dis. 2014. PMID: 24486621
Versatile and efficient targeting using a single nanoparticulate platform: application to cancer and Alzheimer's disease.
Le Droumaguet B, Nicolas J, Brambilla D, Mura S, Maksimenko A, De Kimpe L, Salvati E, Zona C, Airoldi C, Canovi M, Gobbi M, Magali N, La Ferla B, Nicotra F, Scheper W, Flores O, Masserini M, Andrieux K, Couvreur P. Le Droumaguet B, et al. Among authors: salvati e. ACS Nano. 2012 Jul 24;6(7):5866-79. doi: 10.1021/nn3004372. Epub 2012 Jul 2. ACS Nano. 2012. PMID: 22725248
570 results